Wellington Management Group LLP Eq Rx, Inc. Transaction History

Wellington Management Group LLP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$2.05 - $5.5 $95,605 - $256,503	-46,637 Reduced 27.32%	124,088 $305,000
Q3 2022 Nov 14, 2022	BUY	$0.94 - $5.99 $69,492 - $442,828	73,928 Added 76.37%	170,725 $845,000
Q4 2021 Feb 11, 2022	BUY	$5.92 - $9.98 $573,038 - $966,034	96,797 New	96,797 $660,000

67.8M

Ticker EQRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 448,140,992
Description
EQRx, Inc., a pharmaceutical company, engages in developing medicines primarily for the treatment of oncology and immune-inflammatory diseases in the United States. The company's pre-registrational programs in Phase III clinical trial include Aumolertinib, an epidermal growth factor receptor (EGFR) inhibitor for the treatment of patients with EG...

Get notified when there are updates to the investment portfolio of Wellington Management Group LLP, based on Form 13F filings with the SEC.

Stay updated on Wellington Management Group LLP with notifications on news.